CEO, Pharmaceutical Segment
Mon, Nov 27, 2023
Nov 27
36,642 shares @ $106.31
Decreased holdings by -51.00%
2nd largest trade (out of 31)
Planned (10b5-1)Abnormally LargeLarge Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Abnormally large trade for this company
Price 23% above 200-day moving average